(Q35129548)

6 August 2017

title

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies (English)

1 reference

6 August 2017

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00079.X

3 January 2024

1 reference

1 reference

2

Magdalena Korecka

1 reference

6 August 2017

4

Lee Goldberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752309

3 January 2024

author name string

Raman Venkataramanan

3

1 reference

6 August 2017

Roy Bloom

5

1 reference

6 August 2017

Leslie M. Shaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752309

3 January 2024

Kenneth L. Brayman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752309

3 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

number of pages

9

1 reference

full work available at URL

inferred from page(s)

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1034/j.1600-6143.2003.00079.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752309

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-6143.2003.00079.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00079.X

https://api.elsevier.com/content/article/PII:S1600613522073130?httpAccept=text/xml

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00079.X

https://api.elsevier.com/content/article/PII:S1600613522073130?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00079.X

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-6143.2003.00079.x/fullpdf

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00079.X

American Journal of Transplantation

3 January 2024

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

534-542

1 reference

Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolate mofetil reduces production of interferon-dependent major histocompatibility complex induction during allograft rejection, probably by limiting clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mini-review: therapeutic drug monitoring in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetics of mycophenolic acid in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolic acid concentrations are associated with cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Impairment of mycophenolate mofetil absorption by iron ion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

The effect of renal insufficiency on mycophenolic acid protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Pharmacodynamic monitoring of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00079.X

7 January 2021

Identifiers

1 reference

6 August 2017

1 reference